Browse by Author "Vellenga, Edo"

Now showing items 1-4 of 4

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.

2011- Pérez Encinas, Manuel Mateo; Montesinos, Pau; Rayón, Chelo; Vellenga, Edo; Brunet, Salut; [et al.]
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy

2019- Labrador, Jorge; Luño, Elisa; Vellenga, Edo; Brunet, Salut; González-Campos, José; [et al.]
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

2018- Martínez-Cuadrón, David; Montesinos, Pau; Vellenga, Edo; Bernal, Teresa; Salamero, Olga; [et al.]
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

2011- Barragán, Eva; Montesinos, Pau; Camos, Mireia; González, Marcos; Calasanz, María J; [et al.]